Endoscope Reprocessing Market (2025 - 2033)

Endoscope Reprocessing Market Summary

The global endoscope reprocessing market size was estimated at USD 1.71 billion in 2024 and is projected to reach USD 3.02 billion by 2033, growing at a CAGR of 6.64% from 2025 to 2033. Growing infections caused by contaminated endoscopes and increasing preference for minimally invasive surgery are anticipated to boost market growth.

According to a study called "Cannulation rates and technical performance evaluation of commercially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis" published in January 2024, the range of infections related to duodenoscopes was between 0.4% to 1%.

The increasing respiratory disease burden, mainly chronic obstructive pulmonary disorders (COPD), is driving market growth rapidly. According to the JAMA Network report, the global prevalence of COPD was estimated to be 10.6% in 2020, which equals 480 million cases across both genders. The report shows that cases are expected to rise by 112 million to 592 million by 2050, which is 9.5% of the population. This indicates a relative increase of 23.3% from 2020 to 2050. As a result, the demand for endoscopic devices is increasing significantly for early disease diagnosis and treatment, which is further propelling the market growth.

Cervical Cancer in the U.S. (2025)

Source: U.S. Department of Health and Human Services & GVR

Furthermore, the convergence of endoscopy and robotics has revolutionized surgical possibilities, providing improved visualization, unparalleled precision, and better patient outcomes. For instance, the endoscopic surgical system from Virtuoso has two needle-sized manipulators that are robotically controlled and operate from the tip of an endoscope to bring the stability and precision of robot-assisted surgery to rigid endoscopy. Moreover, increasing numbers of successful clinical trials are expected to boost the product approvals. In January 2023, Agilis Robotics, a prominent developer of flexible robotic instruments, completed the second round of live animal testing with its proprietary robot for endoscopic surgery. The test results were satisfactory and demonstrated promising outcomes for the firm's medical robotic system's efficacy, accuracy, and safety. Thus, increasing integration of robotics in endoscopic surgery will lead to a rise in the number of procedures, thereby driving market growth.

Rising funding and investment in R&D activities for improved endoscope products are anticipated to spur market growth. In January 2023, IQ Endoscopes, a medical device company, secured a USD 6.6 million investment in a funding round led by BGF. The investment will support the development and launch of IQ Endoscope’s medical device, which is designed for early diagnosis of a range of cancers and other gastrointestinal conditions. Thus, the increasing launch of endoscopy devices will propel endoscope reprocessing.

Furthermore, regulatory bodies such as the FDA (Food and Drug Administration) and CDC (Centers for Disease Control and Prevention) have established guidelines and standards for reprocessing endoscopes to reduce the risk of infections associated with endoscopic procedures. Adherence to these regulations is a significant driver for adopting advanced endoscope reprocessing systems and solutions. In April 2022, the FDA issued a recall and instructed healthcare providers to use different reprocessing methods for certain urological endoscopes manufactured by Karl Storz.

Market Concentration & Characteristics

The endoscope reprocessing industry has seen significant innovation in recent years, due to technological advances, strict regulatory requirements, and concerns about infection control. There has been a shift towards developing automated reprocessing systems with advanced features to improve efficiency and reduce the risk of human error. These systems use cutting-edge technologies like robotics, artificial intelligence (AI), and advanced sensors to streamline the reprocessing workflow and minimize the potential for contamination.

The endoscope reprocessing industry is characterized by the leading players' high level of merger and acquisition (M&A) activity. This is due to several factors, including the desire to expand the business to cater to the growing demand for endoscope reprocessing. In November 2023, HOYA Corporation acquired WASSENBURG Medical B.V., a global manufacturer of endoscope reprocessing systems, consumables, and services.

Regulations are crucial in shaping the endoscope reprocessing industry, as they ensure patient safety and maintain the efficacy of medical devices. Endoscopes are essential tools in modern healthcare for diagnosing and treating various medical conditions. However, their intricate design and direct contact with bodily fluids pose significant challenges for effective cleaning and disinfection, making stringent regulations necessary.

Product substitutes refer to alternative methods or technologies that healthcare facilities can use instead of traditional reprocessing procedures. One notable substitute in the market is single-use, disposable endoscopes. These devices are designed for one-time use and eliminate the need for reprocessing.

Several market players are expanding their business by entering new geographical regions to strengthen their market position and product portfolio. Rising product launches create more opportunities for market players to enter new areas. In February 2025, Nanosonics continued to advance its strategic product expansion efforts, focusing on ultrasound and endoscope reprocessing technologies and digital health innovations. During this period, the company allocated USD 16.4 million towards research and development, reflecting a 1% increase from the previous year. Notably, around two-thirds of this R&D investment was dedicated to developing CORIS, the company’s upcoming endoscope reprocessing platform, highlighting its commitment to innovation in infection prevention.

Product Insights

By product, the high-level disinfectants and test strips segment dominated the market in 2024 and accounted for the largest revenue share of 29.7%. The healthcare industry is focusing more on preventing and controlling infections in healthcare facilities, which is leading to market growth. Healthcare-associated infections (HAIs) continue to be a significant threat to patient safety, so healthcare facilities are prioritizing the implementation of strict disinfection protocols for endoscopes. An NIH article published in 2022 reports that after GI endoscopic procedures, the composite infection rate was found to be 0.2%, while it was 0.8% following Endoscopic retrograde cholangiopancreatography (ERCP), 0.123% following non-ERCP upper GI endoscopic procedures, and 0.073% following lower GI endoscopic procedures. High-level disinfectants are crucial in eliminating microorganisms from endoscopic instruments, such as bacteria, viruses, and fungi. This helps to reduce the risk of cross-contamination and transmission of infectious agents between patients, thereby supplementing segmental growth.

Automated endoscope reprocessors (AERs) is anticipated to witness the fastest CAGR over the forecast period. Technological advancements in AERs contribute to market growth. Manufacturers continuously improve AERs to enhance their functionality, efficiency, and safety features. Advanced AERs are equipped with high-level disinfection cycles, endoscope-specific adapters, and compatibility with a wide range of endoscope models. For instance, ASP's AEROFLEX AER is an automated system designed explicitly for endoscope reprocessing. The AER comes with an integrated minimum recommended concentration (MRC) monitor. This eliminates the need for test strips. The AER has a complete cycle time of only 22 minutes, making it a highly efficient solution for endoscope reprocessing.

End-use Insights

The Ambulatory Surgical Centers (ASCs) facilities segment dominated the market in 2024 with a revenue share of 56.5%. Outpatient settings, including ASCs, are witnessing a surge in the volume of endoscopic procedures, thereby escalating segmental growth. According to an article published by McMahon Publishing in 2024, the number of surgical procedures performed at ASCs is expected to increase by at least 25% in the next 10 years. Moreover, integrating artificial intelligence (AI) and digitalization into the endoscopy procedure drives segmental growth. In January 2024, Omega Healthcare and Sanjivani Gastro Liver Clinic introduced AI-enabled endoscopy in Odisha to aid in diagnosing and treating gastrointestinal disorders.

The hospitals segment is anticipated to grow significantly over the forecast period. Hospitals play a crucial role in providing medical procedures, diagnostics, and treatments, including a diverse range of endoscopic procedures. Hospitals need reliable endoscope reprocessing solutions to ensure high patient care and infection prevention standards. The rising prevalence of chronic diseases and patient preference for hospitals drive market growth.

Regional Insights

North America dominated the endoscope reprocessing market in 2024 and accounted for the largest revenue share of 38.3% owing to a well-established healthcare infrastructure and high healthcare expenditure. In addition, the increasing prevalence of gastrointestinal diseases, cancer, and other medical conditions requiring endoscopic procedures contributes to market growth in North America. For instance, according to the GI Alliance report, 62 million Americans are diagnosed with digestive disorders each year.

U.S. Endoscope Reprocessing Market Trends

The endoscope reprocessing market in the U.S. held the largest share, 82.8%, in 2024. Increasing cases of gastrointestinal diseases and the high volume of endoscopic procedures performed annually are driving the market growth. For instance, according to the ResearchGate article, in the U.S., more than 17.7 million gastrointestinal (GI) endoscopic procedures are performed every year, making up 68% of all endoscopic procedures.

Canada endoscope reprocessing market is anticipated to register the fastest growth rate during the forecast period. Growing demand for surgeries with fewer post-surgery infections, faster recovery, reduced scarring, better bleeding control, and less pain is expected to boost the demand for endoscope devices, thereby fostering market growth.

Europe Endoscope Reprocessing Market Trends

The endoscope reprocessing market in Europe is anticipated to register a significant growth rate during the forecast period. Growing product launches and approvals in the region are accelerating the market growth. In June 2023, PENTAX Medical Europe, a part of the HOYA Group, introduced a brushless automated pre-cleaning solution for endoscopes called AquaTYPHOON.

Germany endoscope reprocessing market is anticipated to grow considerably during the forecast period. A growing number of endoscopy procedures and increasing technological advancements in endoscopy devices are anticipated to escalate market growth. According to the GlobalData report, in 2022, the total number of endoscopy procedures in Germany was 315,002.

The endoscope reprocessing market in the UK is anticipated to grow considerably during the forecast period. Rising investment from public and private investors in endoscopy services will escalate market growth. In October 2023, Clearview Endoscopy Limited, a company that provides maintenance, repair, and servicing of flexible endoscopes used for medical diagnosis in healthcare settings, received an investment of USD 7.7 million from Foresight.

Spain endoscope reprocessing market is anticipated to register a significant growth rate during the forecast period. Increased prevalence of cancer, such as lung and stomach cancer, is boosting market growth. Increasing colorectal cancer cases in Spain drive market growth. According to the Spanish Network of Cancer Registries article published in March 2025, an estimated 44,500 new cases are projected in 2025. The disease shows a higher prevalence among men, with a ratio of three male cases for every two in women. In spite of a stable incidence trend, colorectal cancer continues to be the second leading cause of cancer-related deaths in the country, accounting for over 15,000 fatalities in 2022-approximately 13.7% of all cancer deaths. This significant burden highlights the vital role of early detection and intervention through endoscopic procedures.

Asia Pacific Endoscope Reprocessing Market Trends

The endoscope reprocessing market in Asia Pacific is anticipated to be the fastest-growing region owing to its rapidly improving healthcare infrastructure, a less stringent regulatory framework, and economic development that attracts foreign investments. Key market players are developing strategies to expand their business in this region. Market growth is expected to be driven by favorable initiatives undertaken by private players, such as training healthcare professionals and increasing R&D investments to develop advanced endoscopes.

Japan endoscope reprocessing market is anticipated to grow significantly during the forecast period. The growing prevalence of chronic diseases and consistent product advancements are some factors expected to drive the demand for endoscopy procedures, further propelling the market growth. For instance, in July 2024, Olympus announced its aim to evolve from an endoscope manufacturer to a diagnostic platform provider by leveraging AI to assist doctors in performing treatments. The Japanese company plans to initiate a trial program in Europe this year to evaluate a cloud-based service connecting hospital endoscopes to its cloud-based software platform.

The endoscope reprocessing market in China is anticipated to grow significantly during the forecast period. Increasing collaborations among market players to develop advanced endoscopes is one of the key factors driving market growth. For instance, in July of 2023, HOYA Group and PENTAX Medical announced the opening of a new facility in Shanghai, China. This center would focus on manufacturing, R&D, and servicing endoscopes for the Chinese market under PENTAX Medical Shanghai Co., Ltd. The facility would produce PENTAX Medical’s endoscopic solutions tailored to the Chinese market.

India endoscope reprocessing market is anticipated to register a significant growth rate during the forecast period. The Union Minister for Health and Family Welfare noted that the number of cancer cases in India was 1,496,972 in 2023, compared to 1,461,427 in 2022. As per an article released by the Press Information Bureau (PIB) in 2023, the nation implemented a population-centered program for the prevention, management, and screening of prevalent Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and common types of cancer under the National Health Mission (NHM) and as part of Comprehensive Primary Health Care. The program aims to screen individuals over 30 for the three common cancers: breast, oral, and cervical. These initiatives aim to increase awareness and enable early cancer diagnosis, fueling market growth.

Latin America Endoscope Reprocessing Market Trends

The endoscope reprocessing market in Latin America is growing over the forecast period, driven by the increasing shift toward minimally invasive procedures and the rising awareness regarding the importance of endoscopy in both diagnostic and therapeutic applications. This growing preference contributes to a greater demand for safe and effective reprocessing systems across the region.

Brazil endoscope reprocessing market is growing over the forecast period. Brazil, the largest economy in Latin America, represents a high-growth potential market for medical devices, including endoscope reprocessing systems. The country's increasing geriatric population and the rising prevalence of chronic diseases such as gastrointestinal (GI) disorders, cardiac valve conditions, sinusitis, and gynecological issues are key drivers of market expansion. According to the Brazilian National Cancer Institute (INCA), Brazil is projected to record approximately 704,000 new cancer cases between 2023 and 2025, emphasizing the growing demand for diagnostic and therapeutic procedures like endoscopy.

Middle East & Africa Endoscope Reprocessing Market Trends

The endoscope reprocessing market in the MEA is growing over the forecast period. The Middle East and Africa (MEA) is an economically diverse yet rapidly developing region, with certain countries such as those in the Gulf Cooperation Council (GCC) boasting high per capita disposable incomes and technologically advanced healthcare systems. Government initiatives to expand reimbursement coverage are expected to boost market growth further over the forecast period.

South Africa endoscope reprocessing market is growing over the forecast period. The market is expected to grow over the forecast period. Increasing colorectal cancer cases drive the market's growth, according to Cansa.org. In April 2024, in South Africa, colorectal cancer represents a significant health concern, with 2022 data from the National Cancer Registry indicating 2,467 newly diagnosed cases in men and 2,221 in women, all confirmed through histological analysis. This equates to a lifetime risk of approximately 1 in 76 for males and 1 in 124 for females, accounting for about 5.9% of all male cancers and 4.85% of all female cancers in the country. The growing incidence of colorectal cancer is driving an increased demand for timely diagnostic procedures such as colonoscopy, which in turn is boosting the need for efficient endoscope reprocessing solutions.

Key Endoscopes Reprocessing Company Insights

Key market participants focus on devising innovative business growth strategies in product portfolio expansions, partnerships & collaborations, mergers & acquisitions, and business footprint expansions.

Recent Developments

• In May 2025, Olympus Corporation introduced the ScopeLocker Air, a specialized endoscope drying cabinet developed to support proper drying and storage protocols in medical facilities. Designed to aid in the final stage of the endoscope reprocessing cycle, this system effectively dries internal channels, aligning with best practice guidelines from health authorities. Manufactured by Capsa Healthcare and offered through Olympus, the cabinet provides a dependable and compliant drying solution to enhance patient safety and streamline endoscope handling.

• In February 2025, Nanosonics continued to advance its strategic product expansion efforts, focusing on ultrasound and endoscope reprocessing technologies and digital health innovations. During this period, the company allocated USD 16.4 million towards research and development, reflecting a 1% increase from the previous year. Notably, around two-thirds of this R&D investment was dedicated to developing CORIS, the company’s upcoming endoscope reprocessing platform, highlighting its commitment to innovation in infection prevention.

• In September 2024, Soluscope and its manufacturing site achieved compliance with the EU Medical Device Regulation (MDR 2017/745), enabling the launch of CE‑marked products such as the Serie XS automated endoscope reprocessor.

Endoscope Reprocessing Market